Differential effect of obesity on prevalence of cardiac and carotid target organ damage in hypertension (the Campania Salute Network).

[1]  G. de Simone,et al.  Effect of diabetes and metabolic syndrome on myocardial mechano-energetic efficiency in hypertensive patients. The Campania Salute Network , 2017, Journal of Human Hypertension.

[2]  G. de Simone,et al.  Left Ventricular Hypertrophy Regression During Antihypertensive Treatment in an Outpatient Clinic (the Campania Salute Network) , 2017, Journal of the American Heart Association.

[3]  R. Virmani,et al.  Pathology of Human Coronary and Carotid Artery Atherosclerosis and Vascular Calcification in Diabetes Mellitus. , 2017, Arteriosclerosis, thrombosis, and vascular biology.

[4]  G. de Simone,et al.  Obesity and hypertensive heart disease: focus on body composition and sex differences , 2016, Diabetology & Metabolic Syndrome.

[5]  Vilmundur Gudnason,et al.  Prevalence and determinants of carotid plaque in the cross-sectional REFINE-Reykjavik study , 2016, BMJ Open.

[6]  G. de Simone,et al.  Depressed myocardial energetic efficiency is associated with increased cardiovascular risk in hypertensive left ventricular hypertrophy , 2016, Journal of hypertension.

[7]  S. Solomon,et al.  Association of Weight and Body Composition on Cardiac Structure and Function in the ARIC Study (Atherosclerosis Risk in Communities) , 2016, Circulation. Heart failure.

[8]  S. Solomon,et al.  Obesity and Subtypes of Incident Cardiovascular Disease , 2016, Journal of the American Heart Association.

[9]  S. Lai,et al.  Obesity Is Associated With Progression of Atherosclerosis During Statin Treatment , 2016, Journal of the American Heart Association.

[10]  G. de Simone,et al.  Aortic root dimension and arterial stiffness in arterial hypertension: the Campania Salute Network , 2016, Journal of hypertension.

[11]  G. de Simone,et al.  Development of new atherosclerotic plaque in hypertensive patients: an observational registry study from the Campania-Salute network , 2015, Journal of hypertension.

[12]  G. Cioffi,et al.  See Clinical Perspective See Editorial by Barasch and Reichek , 2022 .

[13]  G. Aurigemma,et al.  Cardiovascular risk in relation to a new classification of hypertensive left ventricular geometric abnormalities , 2015, Journal of hypertension.

[14]  T. Naqvi,et al.  Carotid intima-media thickness and plaque in cardiovascular risk assessment. , 2014, JACC. Cardiovascular imaging.

[15]  B. Howard,et al.  Cardiometabolic risk in overweight subjects with or without relative fat-free mass deficiency: the Strong Heart Study. , 2014, Nutrition, metabolism, and cardiovascular diseases : NMCD.

[16]  Michael Böhm,et al.  2013 ESH/ESC Practice Guidelines for the Management of Arterial Hypertension , 2014, Blood pressure.

[17]  G. de Simone,et al.  Left ventricular geometry in obesity: Is it what we expect? , 2013, Nutrition, metabolism, and cardiovascular diseases : NMCD.

[18]  G. de Simone,et al.  Hypertensive target organ damage predicts incident diabetes mellitus , 2013, European heart journal.

[19]  M. Nieminen,et al.  Impact of overweight and obesity on cardiac benefit of antihypertensive treatment. , 2013, Nutrition, metabolism, and cardiovascular diseases : NMCD.

[20]  G. de Simone,et al.  Classes of antihypertensive medications and blood pressure control in relation to metabolic risk factors , 2012, Journal of hypertension.

[21]  J. J. Rivera,et al.  Association Between Obesity, High-Sensitivity C-Reactive Protein ≥2 mg/L, and Subclinical Atherosclerosis: Implications of JUPITER from the Multi-Ethnic Study of Atherosclerosis , 2011, Arteriosclerosis, thrombosis, and vascular biology.

[22]  Raffaele Izzo,et al.  Initial left-ventricular mass predicts probability of uncontrolled blood pressure in arterial hypertension , 2011, Journal of hypertension.

[23]  V. Basevi.  Diagnosis and Classification of Diabetes Mellitus , 2011, Diabetes Care.

[24]  G. de Simone,et al.  Does Information on Systolic and Diastolic Function Improve Prediction of a Cardiovascular Event by Left Ventricular Hypertrophy in Arterial Hypertension? , 2010, Hypertension.

[25]  A. Folsom,et al.  Associations of Obesity Measures with Subtypes of Ischemic Stroke in the ARIC Study , 2010, Journal of epidemiology.

[26]  R. Kronmal,et al.  The impact of obesity on the left ventricle: the Multi-Ethnic Study of Atherosclerosis (MESA). , 2010, JACC. Cardiovascular imaging.

[27]  G. de Simone,et al.  Clustered metabolic abnormalities blunt regression of hypertensive left ventricular hypertrophy: the LIFE study. , 2009, Nutrition, metabolism, and cardiovascular diseases : NMCD.

[28]  E. Lonn,et al.  The differential association between various anthropometric indices of obesity and subclinical atherosclerosis. , 2009, Atherosclerosis.

[29]  C. Schmid,et al.  A new equation to estimate glomerular filtration rate. , 2009, Annals of internal medicine.

[30]  P. Okin,et al.  Gender Differences in Left Ventricular Structure and Function During Antihypertensive Treatment: The Losartan Intervention for Endpoint Reduction in Hypertension Study , 2008, Hypertension.

[31]  A. Hofman,et al.  The female advantage in cardiovascular disease: do vascular beds contribute equally? , 2007, American journal of epidemiology.

[32]  S. Hunt,et al.  Left Ventricular Hypertrophy in Severe Obesity: Interactions Among Blood Pressure, Nocturnal Hypoxemia, and Body Mass , 2007, Hypertension.

[33]  A. Folsom,et al.  Risk Factors for Ischemic Stroke Subtypes: The Atherosclerosis Risk in Communities Study , 2006, Stroke.

[34]  William Stewart,et al.  Recommendations for chamber quantification. , 2006, European journal of echocardiography : the journal of the Working Group on Echocardiography of the European Society of Cardiology.

[35]  Richard B Devereux,et al.  Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardio , 2005, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[36]  C. Papamichael,et al.  Adolescent obesity is associated with high ambulatory blood pressure and increased carotid intimal-medial thickness. , 2005, The Journal of pediatrics.

[37]  M. Nieminen,et al.  Body Build and Risk of Cardiovascular Events in Hypertension and Left Ventricular Hypertrophy: The LIFE (Losartan Intervention For Endpoint reduction in hypertension) Study , 2005, Circulation.

[38]  L. Wilhelmsen,et al.  Body Mass Index in Mid-Life Is Associated With a First Stroke in Men: A Prospective Population Study Over 28 Years , 2004, Stroke.

[39]  R. Garrison,et al.  Body Mass Index and Blood Pressure Influences on Left Ventricular Mass and Geometry in African Americans: The Atherosclerotic Risk In Communities (ARIC) Study , 2004, Hypertension.

[40]  E. Mannarino,et al.  Prognostic value of the metabolic syndrome in essential hypertension. , 2004, Journal of the American College of Cardiology.

[41]  P. Macfarlane,et al.  Metabolic Syndrome With and Without C-Reactive Protein as a Predictor of Coronary Heart Disease and Diabetes in the West of Scotland Coronary Prevention Study , 2003, Circulation.

[42]  Ralph B D'Agostino,et al.  Overweight and obesity as determinants of cardiovascular risk: the Framingham experience. , 2002, Archives of internal medicine.

[43]  G. de Simone,et al.  Estimation of left ventricular chamber and stroke volume by limited M-mode echocardiography and validation by two-dimensional and Doppler echocardiography. , 1996, The American journal of cardiology.

[44]  Y. Handelsman,et al.  TRIGLYCERIDES, ATHEROSCLEROSIS, AND CARDIOVASCULAR OUTCOME STUDIES: FOCUS ON OMEGA-3 FATTY ACIDS. , 2017, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

[45]  2007 ESH-ESC Practice Guidelines for the Management of Arterial Hypertension , 2007 .